English

In this episode of Beyond Substance podcast, Jason Rush shares his journey through addiction and hepatitis C, while Dr. Janet Arno provides expert insight on treatment and public health solutions.

This journal explores the evolution of HIV diagnostic testing, from early antibody-based methods to advanced molecular and rapid point-of-care technologies. It highlights the impact of these innovations on early detection, treatment initiation, and global efforts to control HIV transmission.

This webinar is about improving maternal health lessons learned from states addressing congenital syphilis.

This report discusses how SARS-CoV-2, the virus that causes COVID-19, rapidly evolves in people with advanced HIV due to weakened immune responses. This prolonged viral replication can lead to the emergence of new variants, highlighting the importance of HIV treatment and COVID-19 prevention efforts in immunocompromised populations.

This journal discusses the role of core group theory in understanding the transmission dynamics of mpox, emphasizing that the virus primarily spreads through sexual contact and behaves similarly to other sexually transmitted infections. It highlights how infection-induced and vaccine-induced immunity within high-risk groups have significantly reduced transmission, making future large-scale outbreaks unlikely, though continued surveillance and vaccination efforts remain essential.

This 30-minute podcast was created in recognition of World TB Day. In the recording, Dr. Zelalem Temesgen discusses TB, including information on TB diagnosis and management.

In this 45-minute webinar, participants are introduced to the fundamentals of TB. Topics include modes of transmission, common symptoms, diagnostic testing protocols, treatment regimens, and more. 

This doxy PEP infographic poster covers what the general public needs to know about doxy PEP.

The doxy PEP action kit is a toolkit that provides resources for patients and providers on doxy PEP.

This report provides an update on national progress in meeting the goals of the National HIV/AIDS Strategy (2022-2025) based on the most current available data and also highlights some recent federal efforts to implement the Strategy.